bevacizumab - Globe Thesis

Keyword [bevacizumab] Result: 181 - 200 \| Page: 10 of 10
181.	Clinical Efficacy Of Bevacizumab Combined With Chemotherapy For Brain Metastases Of Lung Adenocarcinoma
182.	The Clinical Observation On The Therapeutic Effect Of Gallnut In Treatment Of Proteinuria Induced By Bevacizumab
183.	A Preliminary Study On The Efficacy Of Bevacizumab Combined With Chemotherapy In The Treatment Of Malignant Abdominaladhesions
184.	The Effect Of Blocking VEGF-C Combined With Bevacizumab On Malignant Biological Behavior Of Gastric Cancer
185.	Effects Of Antibiotics On The Efficacy Of Bevacizumab-based Treatment In Metastatic Colorectal Cancer
186.	The Adverse Events Of Bevacizumab In Combination With Chemotherapy For Recurrent Ovarian Cancer:a Meta Analysis
187.	A Meta-Analysis Of The Efficacy And Safety Of Bevacizumab In The Maintenance Of Advanced Colorectal Cancer
188.	Clinical Observation Of Amlodipine Besylate And Telmisartan In The Treatment Of Patients With Hypertension Induced By Bevacizumab
189.	The Efficacy Of Bevacizumab In The Treatment Of Colorectal Cancer:A Meta-Analysis
190.	Radiomics Analysis For Evaluation Of Therapeutic Response To Chemotherapy Combined With Bevacizumab In Colorectal Liver Metastases
191.	Efficacy And Safety Of Intraperitoneal Bevacizumab Combined With Chemotherapeutic Agents In The Treatment Of Malignant Ascites:A Meta-analysis
192.	The Efficacy Of First-line Chemotherapy Regimens Combined With Bevacizumab And The Relationship Between The Efficacy And The Status Of RAS And BRAF Genes In Metastatic Colorectal Cancer
193.	Efficacy Of Bevacizumab Combined With Chemotherapy As First-line And Second-line Treatment In Metastatic Colorectal Cancer
194.	The Efficacy Of Adding Targeted Agents To Neoadjuvant Therapy For Locally Advanced Rectal Cancer Patients: A Meta-analysis
195.	Clinical Study Of Traditional Chinese Medicine Combines With Chemotherapy And Bevacizumab In The Treating Of Metastatic Colorectal Cancer
196.	Investigate Anti-angiogenesis Effect Of Bevacizumab And The Optimal Time Window Of Combined Chemotherapy
197.	The Risk Of Hemorrhage In Non-small Cell Lung Cancer Patients Treated With Bevacizumab:A Meta-analysis
198.	The Effect Of Low-expression PDCL3 On VEGF In SKOV3 Cell Line
199.	Clinical Study Of Bevacizumab Combined With WBRT In The Treatment Of Brain Metastasis Of Lung Adenocarcinoma
200.	Expression Of HOXB9 In Colorectal Carcinoma Tissues And Its Relationship With Micro-angiogenesis
<<First <Prev Next> Last>> Jump to